[New psychoactive substances require a paradigm shift in drug testing in Denmark]

Area of Science:

• Forensic Chemistry
• Toxicology
• Public Health

Background:

• The increasing prevalence of new psychoactive substances (NPS) poses significant challenges to traditional drug testing protocols.
• Existing immunoassay screening methods lack the specificity and sensitivity required for accurate NPS detection.
• There is a growing need for reliable data on NPS use, public health impact, and clinical implications in Denmark.

Purpose of the Study:

• To highlight the urgent need for a paradigm shift in drug testing methodologies due to the emergence of NPS.
• To advocate for the replacement of immunoassay screening with advanced analytical techniques.
• To emphasize the importance of developing and implementing new methods for accurate NPS detection and data collection in Denmark.

Main Methods:

• Discusses the limitations of current immunoassay screening for NPS.
• Highlights the advantages of chromatography and mass spectrometry for NPS analysis.
• Addresses the challenges in developing and implementing novel analytical methods in clinical and forensic settings.

Main Results:

• New psychoactive substances (NPS) require more sophisticated detection methods than standard immunoassays.
• Chromatography and mass spectrometry offer superior specificity and sensitivity for NPS identification.
• The development and implementation of these advanced methods are critical for accurate drug testing.

Conclusions:

• A transition from immunoassay screening to advanced analytical methods like chromatography and mass spectrometry is essential for effective NPS detection.
• Accurate NPS testing is vital for patient safety, public health surveillance, and clinical management in Denmark.
• Overcoming the challenges in method development is crucial for forensic and clinical laboratories to address the NPS issue effectively.